Prakt. lékáren. 2022; 18(1): 9-13 | DOI: 10.36290/lek.2022.001

Treatment and diagnostics of cancer in gravidity

Roman Goněc
Ústavní lékárna, Masarykův onkologický ústav, Brno

Cancer in pregnancy is rare, and its diagnostics and treatment might brings some challanges. The patient, the fetus, and the course of gravidity should not be put in danger. The pregnancy may make diagnostic both more diffucult and delayed because of its unspecific symptoms. Any procedure has to be carefully discussed, mainly with respect to the stage of gravidity because particular risks are different in the course of gravidity. Not only there are teratogenic effects of drugs and radioation which are most prominent in the first trimester, but there are also interferences with the gravidity or side effects occurring both in the mother and the fetus/newborn. Nevertheless, an pro­‑active approach to cancer treatment in gravidity is desirable

Keywords: gravidity, chemotherapy, nursing, cancer.

Published: March 14, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Goněc R. Treatment and diagnostics of cancer in gravidity. Praktické lékárenství. 2022;18(1):9-13. doi: 10.36290/lek.2022.001.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Basta P, Bak A, Roszkowski K. Cancer treatment in pregnant women. Contemp Oncol (Pozn). 2015;19(5):354,360. Go to original source... Go to PubMed...
    2. Hepner A, Negrini D, Hase EA, et al. Cancer during pregnancy: the oncologist overview. World J Oncol 2019;10(1):28-34. Go to original source... Go to PubMed...
    3. Eibye S, Kjær SK, Mellemkjær L. Incidence of pregnancy­‑associated cancer in Denmark, 1977-2006. Obstet Gynecol 2013;122:608-17. Go to original source... Go to PubMed...
    4. Koren G, Carey N, Gagnon R, et al. Cancer chemotherapy and pregnancy. J Obstet Gynaecol Can. 2013;35(3):263-278. Go to original source... Go to PubMed...
    5. Andersson TM, Johansson AL, Fredriksson I, Lambe M. Cancer during pregnancy and the postpartum period: A population­‑based study. Cancer. 2015;121(12):2072-2077. Go to original source... Go to PubMed...
    6. Dauer LT, Thornton RH, Miller DL, et al. Radiation management for interventions using fluoroscopic or computed tomographic guidance during pregnancy: a joint guideline of the Society of Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe with Endorsement by the Canadian Interventional Radiology Association. J Vasc Interv Radiol. 2012;23(1):19-32. Go to original source... Go to PubMed...
    7. Committee on Obstetric Practice. Committee Opinion No. 723: Guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol. 2017;130(4):e210-e216 Go to original source... Go to PubMed...
    8. Aktuální vydání je dostupné na https://www.linkos.cz/lekar­‑a-multidisciplinarni­‑tym/personalizovana­‑onkologie/modra­‑kniha­‑cos/
    9. Silverstein J, Post AL, Chien AJ, et al. Multidisciplinary management of cancer during pregnancy. JCO Oncol Pract. 2020;16:545-557. Go to original source... Go to PubMed...
    10. Ní Mhuireachtaigh R, O'Gorman DA. Anesthesia in pregnant patients for nonobstetric surgery. J Clin Anesth. 2006; 18:60-66. Go to original source... Go to PubMed...
    11. Kal HB, Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol. 2005;6(5):328-333. Go to original source... Go to PubMed...
    12. Babb M, Koren G, Einarson A. Treating pain during pregnancy. Can Fam Physician. 2010;56(1):25-27. Go to PubMed...
    13. Wolters V, Heimovaara J, Maggen C, et al. Management of pregnancy in women with cancer. Int J Gynecol Cancer. 2021;31:314-322. Go to original source... Go to PubMed...
    14. Vandenbroucke T, Verheecke M, Fumagalli M, et al. Effects of cancer treatment during pregnancy on fetal and child development. Lancet Child Adolesc Health. 2017;1:302-310. Go to original source... Go to PubMed...
    15. Braems G, Denys H, De Wever O, et al. Use of tamoxifen before and during pregnancy. Oncologist. 2011;16(11):1547-1551. Go to original source... Go to PubMed...
    16. Zagouri F, Sergentanis TN, Chrysikos D, et al. Trastuzumab administration during pregnancy: a systematic review and meta­‑analysis. Breast Cancer Res Treat 2013;137:349-357. Go to original source... Go to PubMed...
    17. Lambertini M, Peccatori FA, Azim HA. Targeted agents for cancer treatment during pregnancy. Cancer Treat Rev. 2015;41:301-309. Go to original source... Go to PubMed...
    18. Poulet FM, Wolf JJ, Herzyk DJ, DeGeorge JJ. An evaluation of the impact of PD-1 pathway blockade on reproductive safety of therapeutic PD-1 inhibitors. Birth Defects Res B Dev Reprod Toxicol. 2016;107(2):108-119. Go to original source... Go to PubMed...
    19. Greer IA, Nelson­‑Piercy C. Low­‑molecular­‑weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: A systematic review of safety and efficacy. Blood. 2005;106:401-407. Go to original source... Go to PubMed...

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.